Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-25-Speech-2-270-937"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-25"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20111025.25.2-270-937"2
lpv:hasSubsequent	lp_eu:2011-10-25-Speech-2-271-0002
lpv:speaker	lp:Paulo Rangel2
lpv:spokenAs	vice-chair; EPP (2009-11-25--2014-06-30)3 substitute; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-30--2014-06-30)3 member; AFCO (2009-07-16--2012-01-18)3 unknown; Partido Social Democrata (2009-07-14--2014-06-30)3 member; Delegation for relations with the United States (2009-09-16--2014-06-30)3 substitute; JURI (2010-10-20--2012-01-18)3
lpv:translated text	"I voted to grant the Executive Director of the European Medicines Agency (EMA) discharge in respect of the implementation of its budget for the financial year 2009 because I believe the various prerequisites have been met. I am, however, bound to stress the need for all the EMA’s activities to be guided by the principle of transparency, particularly public procurement processes. Indeed, the observation of the Court of Auditors that the EMA did not undertake the necessary checks to reduce the risk of error relating to calls for proposals under a given range of circumstances elicits a degree of suspicion. As such, I hope that, from now on, the necessary efforts will be made to reduce conflict of interest situations so that, at the very least, guarantees of consumer protection will not be threatened."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph